Holen Sie sich die Stockscreener-App
4.60
2.45%
0.11
Schlusskurs vom Vortag:
$4.49
Offen:
$4.48
24-Stunden-Volumen:
22,003
Relative Volume:
0.14
Marktkapitalisierung:
$36.26M
Einnahmen:
$2.34M
Nettoeinkommen (Verlust:
$-30.37M
KGV:
-1.5633
EPS:
-2.9424
Netto-Cashflow:
$-23.42M
1W Leistung:
+5.75%
1M Leistung:
-3.16%
6M Leistung:
-35.30%
1J Leistung:
+2.68%
1-Tages-Spanne:
$4.43
$4.60
1-Wochen-Bereich:
$4.3001
$4.67
52-Wochen-Spanne:
$3.62
$16.25
Radiopharm Theranostics Ltd Adr Stock (RADX) Company Profile
Firmenname
Radiopharm Theranostics Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare RADX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RADX
Radiopharm Theranostics Ltd Adr
|
4.60 | 36.74M | 2.34M | -30.37M | -23.42M | -2.9424 |
VRTX
Vertex Pharmaceuticals Inc
|
444.28 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
755.51 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
828.35 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
339.41 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
310.00 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
Radiopharm Theranostics Ltd Adr Stock (RADX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Eingeleitet | B. Riley Securities | Buy |
Radiopharm Theranostics Ltd Adr Aktie (RADX) Neueste Nachrichten
Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial - GlobeNewswire Inc.
Analysts Offer Insights on Healthcare Companies: AbSci (ABSI) and RenovoRx (RNXT) - The Globe and Mail
Radiopharm Theranostics Shares RAD101 Phase IIb Update: 90% Hit Primary Endpoint in Brain Mets Study - Yahoo Finance
Radiopharm Theranostics Highlights 90% Positive RAD101 Interim Data, Eyes Phase III FDA Talks - Yahoo Finance
Radiopharm Theranostics LimitedSponsored ADR (NASDAQ:RADX) Given Average Rating of "Buy" by Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Citius Oncology (CTOR) and Oruka Therapeutics (ORKA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Sana Biotechnology (SANA) and Rapport Therapeutics, Inc. (RAPP) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI) and Shattuck Labs (STTK) - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Ocugen (OCGN) - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Atai Beckley N.V. (ATAI) - The Globe and Mail
Radiopharm Theranostics Doses First Patient in Phase 1/2a Trial of 177Lu-BetaBart - TipRanks
Analysts’ Top Healthcare Picks: Praxis Precision Medicines (PRAX), Beyond Air (XAIR) - The Globe and Mail
Radiopharm Theranostics Limited – Sponsored ADR (NASDAQ:RADX) Given Consensus Rating of “Buy” by Brokerages - Defense World
Fifth Third Bancorp (NASDAQ:FITB) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Hartford Multifactor Emerging Markets ETF (NYSEARCA:ROAM) Short Interest Up 110.6% in January - Defense World
Radiopharm Theranostics Limited – Sponsored ADR (NASDAQ:RADX) Sees Significant Increase in Short Interest - Defense World
Short Interest in Azitra, Inc. (NYSEAMERICAN:AZTR) Expands By 112.1% - Defense World
GeoVax Labs Inc. (NASDAQ:GOVX) Short Interest Update - Defense World
iShares Environmentally Aware Real Estate ETF (NASDAQ:ERET) Sees Significant Increase in Short Interest - Defense World
Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Icon (ICLR) and Perspective Therapeutics (CATX) - The Globe and Mail
Radiopharm Theranostics (NASDAQ:RADX) versus Bolt Biotherapeutics (NASDAQ:BOLT) Head-To-Head Survey - Defense World
Analysts Offer Insights on Healthcare Companies: Radiopharm Theranostics Limited Sponsored ADR (RADX) and Resmed (RMD) - The Globe and Mail
Radiopharm Theranostics (ASX:RAD) Prepares for Multiple 2026 Readouts with Firm Cash Position - Kalkine Media
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates - Sahm
Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Radiopharm Theranostics (NASDAQ:RADX) Lowered to Strong Sell Rating by Wall Street Zen - MarketBeat
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV) and Praxis Precision Medicines (PRAX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Travere Therapeutics (TVTX) and Beyond Air (XAIR) - The Globe and Mail
Radiopharm Theranostics Lifts Stake in MD Anderson Joint Venture to 87.5% as Lead B7H3 Drug Enters Clinic - TipRanks
RAD Increases Ownership in Radiopharm Ventures to 87.5% - Sahm
RADX: Interim Readout Achieves 92% Concordance - Research Tree
Equities Analysts Issue Forecasts for RADX FY2026 Earnings - Defense World
RADX FY2026 EPS Reduced by Brookline Capital Management - MarketBeat
Analysts’ Top Healthcare Picks: Foghorn Therapeutics (FHTX), Eton Pharmaceuticals (ETON) - The Globe and Mail
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.62% - Investing.com India
Radiopharm Theranostics (NASDAQ:RADX) Receives Buy Rating from B. Riley - Defense World
Buy Rating for Radiopharm Theranostics Limited Driven by Promising Clinical Developments and Growth Potential - TipRanks
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.62% - Investing.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.62% - Investing.com UK
Radiopharm Theranostics (NASDAQ:RADX) Earns "Buy" Rating from B. Riley - MarketBeat
Dow Falls 50 Points; US Adds 64,000 Jobs In November - Benzinga
Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Benzinga
US stock market crash today: Dow, S&P 500, Nasdaq slide deep into the red — why is the stock market down today? - MSN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.09% - Investing.com UK
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.09% - Investing.com
United States shares lower at close of trade; Dow Jones Industrial Average down 0.09% - Investing.com India
Radiopharm (RADX) Sees Slight Pessimism From Analysts - Finviz
US stock market crash today: Dow, S&P 500, Nasdaq slide deep into the red — why is the stock market down t - The Economic Times
Radiopharm Theranostics interim data shows 92% reach endpoint in RAD101 study - Investing.com Canada
Radiopharm Theranostics stock soars after positive brain metastases trial data - Investing.com
Finanzdaten der Radiopharm Theranostics Ltd Adr-Aktie (RADX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):